Neogenomics (NEO) EBIT Growth (3y) (2013 - 2026)
Neogenomics (NEO) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -31.42% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 6.03% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -3.96% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 8.95% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 12.23% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 1.37% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 2.95% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 73.97% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -3.05% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | 19.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.58% |
| Dec 31, 2025 | 20.19% |
| Sep 30, 2025 | 11.90% |
| Jun 30, 2025 | -6.26% |
| Mar 31, 2025 | 18.83% |
| Dec 31, 2024 | 23.79% |
| Sep 30, 2024 | 18.88% |
| Jun 30, 2024 | 0.64% |
| Mar 31, 2024 | -26.48% |
| Dec 31, 2023 | -74.93% |
| Sep 30, 2023 | -92.94% |
| Jun 30, 2023 | -16.50% |
| Mar 31, 2023 | -87.83% |
| Dec 31, 2022 | -137.33% |
| Sep 30, 2022 | -133.91% |
| Jun 30, 2022 | -121.49% |
| Mar 31, 2022 | -181.97% |
| Dec 31, 2021 | -155.78% |
| Sep 30, 2021 | -129.77% |
| Jun 30, 2021 | -211.31% |